Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-016664
Filing Date
2020-06-16
Accepted
2020-06-16 17:03:33
Documents
1
Period of Report
2020-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8649
  Complete submission text file 0000899243-20-016664.txt   10224
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CAY HOUSE EP TAYLOR DRIVE N7776 LYFORD CAY, NEW PROVIDENCE C5 00000
Business Address CAY HOUSE EP TAYLOR DRIVE N7776 LYFORD CAY, NEW PROVIDENCE C5 00000 407-909-9970
Braslyn Ltd. (Reporting) CIK: 0001642355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 20967150